Analyst Ratings For NASDAQ:KTOV – KITOV PHARMA LT/S (NASDAQ:KTOV)
Today, HC Wainwright reiterated its Buy rating on NASDAQ:KTOV – KITOV PHARMA LT/S (NASDAQ:KTOV) with a price target of $12.50.
Some recent analyst ratings include
- 6/6/2018-HC Wainwright Reiterated Rating of Buy.
- 7/11/2016-Rodman & Renshaw Reiterated Rating of Buy.
Recent Trading Activity for NASDAQ:KTOV – KITOV PHARMA LT/S (NASDAQ:KTOV)
Shares of NASDAQ:KTOV – KITOV PHARMA LT/S closed the previous trading session at with 1576955 shares trading hands.